Livingston, NJ -- The Renal and Pancreas Transplant Division at Cooperman Barnabas Medical Center (CBMC) recently welcomed its newest transplant surgeon, Matthew Rosenzweig, DO. Dr. Rosenzweig joins Stuart R. Geffner, MD, and Harry Sun, MD, with Associates in Transplant and General Surgery, and James Guarrera, MD, and the transplant surgeons from Rutgers-New Jersey Medical School and University Hospital in Newark, NJ. Together, they form New Jersey’s largest and most experienced group of transplant surgeons, specializing in renal and pancreas transplantation, dialysis access, and general and advanced laparoscopic surgery.
Prior to joining the Division, Dr. Rosenzweig completed a fellowship in abdominal transplant surgery at Baylor Simmons Transplant Institute, at Baylor University Medical Center, Dallas, TX. He also completed a general surgery residency at Hackensack UMC-Palisades Medical Center, North Bergen, NJ, and trained as a Doctor of Osteopathic Medicine at New York College of Osteopathic Medicine, Old Westbury, NY. Dr. Rosenzweig is board certified in surgery and has extensive clinical research experience. A member of the American Society of Transplant Surgeons, he recently served on the organization’s Strategic Planning: TACC/Training & Certification Workgroup.
The Renal and Pancreas Transplant Division, located in Livingston, NJ, is one of the leading kidney transplant centers in the country. In 2021, the program performed 348 kidney transplants, making CBMC the largest kidney transplant center in the Northeast and one of the largest in the country. In addition, CBMC was the fourth largest living donor kidney transplant program in the U.S., performing 131 kidney transplants from living donors.
In addition to these transplant surgeons, the Transplant Division includes eight transplant nephrologists, a transplant urologist, and a large and dedicated team of transplant coordinators, advanced practice providers, social workers, pharmacists, and dietitians. The program also conducts extensive clinical research that allows patients to participate in trials of new medications, therapies, and diagnostic tools. CBMC’s experienced and multi-disciplinary transplant team seeks to ensure that patients receive the greatest possible benefit from kidney and pancreas transplantation and achieve excellent long-term transplant outcomes. Learn more.